223 related articles for article (PubMed ID: 16858853)
1. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital.
Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853
[TBL] [Abstract][Full Text] [Related]
2. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
Wananukul S; Nuchprayoon I; Siripanich H
J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
[TBL] [Abstract][Full Text] [Related]
4. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
[TBL] [Abstract][Full Text] [Related]
5. Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome.
Stabell N; Nordal E; Stensvold E; Gammelsrud KW; Lund B; Taxt A; Buhring F; Greve-Isdahl M; Fornebo HP; Simonsen GS; Klingenberg C
Scand J Infect Dis; 2008; 40(4):301-7. PubMed ID: 17918015
[TBL] [Abstract][Full Text] [Related]
6. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
7. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.
Bakhshi S; Padmanjali KS; Arya LS
Pediatr Hematol Oncol; 2008 Jun; 25(5):385-92. PubMed ID: 18569840
[TBL] [Abstract][Full Text] [Related]
8. Risk prediction in pediatric cancer patients with fever and neutropenia.
Hakim H; Flynn PM; Srivastava DK; Knapp KM; Li C; Okuma J; Gaur AH
Pediatr Infect Dis J; 2010 Jan; 29(1):53-9. PubMed ID: 19996816
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
Latiff Z; Zulkifli SZ; Jamal R
Malays J Pathol; 2002 Dec; 24(2):83-9. PubMed ID: 12887165
[TBL] [Abstract][Full Text] [Related]
10. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
11. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
[TBL] [Abstract][Full Text] [Related]
13. Evolving concepts of management of febrile neutropenia in children with cancer.
Orudjev E; Lange BJ
Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
15. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
16. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
17. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.
Dommett R; Geary J; Freeman S; Hartley J; Sharland M; Davidson A; Tulloh R; Taj M; Stoneham S; Chisholm JC
Eur J Cancer; 2009 Nov; 45(16):2843-9. PubMed ID: 19616427
[TBL] [Abstract][Full Text] [Related]
18. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.
Hamzeh F; Kanj SS; Uwaydah M
J Med Liban; 2000; 48(3):136-42. PubMed ID: 11268566
[TBL] [Abstract][Full Text] [Related]
19. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.
Kuderer NM; Dale DC; Crawford J; Cosler LE; Lyman GH
Cancer; 2006 May; 106(10):2258-66. PubMed ID: 16575919
[TBL] [Abstract][Full Text] [Related]
20. Febrile episodes in childhood malignancies.
Dubey AP; Singhal D; Prakash SK
Indian Pediatr; 2002 Oct; 39(10):952-7. PubMed ID: 12428042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
